These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23469107)

  • 1. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis.
    Mori S; Tran V; Nishikawa K; Kaneda T; Hamada Y; Kawaguchi N; Fujita M; Saegusa J; Takada YK; Matsuura N; Zhao M; Takada Y
    PLoS One; 2013; 8(2):e57927. PubMed ID: 23469107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.
    Yamaji S; Saegusa J; Ieguchi K; Fujita M; Mori S; Takada YK; Takada Y
    PLoS One; 2010 Apr; 5(4):e10273. PubMed ID: 20422052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis.
    Mori S; Hatori N; Kawaguchi N; Hamada Y; Shih TC; Wu CY; Lam KS; Matsuura N; Yamamoto H; Takada YK; Takada Y
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28302677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.
    Mori S; Wu CY; Yamaji S; Saegusa J; Shi B; Ma Z; Kuwabara Y; Lam KS; Isseroff RR; Takada YK; Takada Y
    J Biol Chem; 2008 Jun; 283(26):18066-75. PubMed ID: 18441324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF1 Suppresses Allosteric Activation of β3 Integrins by FGF2: A Potential Mechanism of Anti-Inflammatory and Anti-Thrombotic Action of FGF1.
    Takada YK; Wu X; Wei D; Hwang S; Takada Y
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
    Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
    J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
    Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
    J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist.
    Chang CC; Takada YK; Cheng CW; Maekawa Y; Mori S; Takada Y
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.
    Chang CC; Takada YK; Cheng CW; Maekawa Y; Mori S; Takada Y
    bioRxiv; 2023 Dec; ():. PubMed ID: 38076804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.
    Forough R; Weylie B; Collins C; Parker JL; Zhu J; Barhoumi R; Watson DK
    J Vasc Res; 2006; 43(4):327-37. PubMed ID: 16682805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.
    Kostas M; Lampart A; Bober J; Wiedlocha A; Tomala J; Krowarsch D; Otlewski J; Zakrzewska M
    J Mol Biol; 2018 Oct; 430(21):4087-4101. PubMed ID: 30099027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
    Wu ZL; Zhang L; Yabe T; Kuberan B; Beeler DL; Love A; Rosenberg RD
    J Biol Chem; 2003 May; 278(19):17121-9. PubMed ID: 12604602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470).
    Chen GJ; Weylie B; Hu C; Zhu J; Forough R
    J Cell Biochem; 2007 Aug; 101(6):1492-504. PubMed ID: 17295210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acacetin inhibits in vitro and in vivo angiogenesis and downregulates Stat signaling and VEGF expression.
    Bhat TA; Nambiar D; Tailor D; Pal A; Agarwal R; Singh RP
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1128-39. PubMed ID: 23943785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.
    Lin B; Song X; Yang D; Bai D; Yao Y; Lu N
    Gene; 2018 May; 654():77-86. PubMed ID: 29454091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity.
    Szlachcic A; Sochacka M; Czyrek A; Opalinski L; Krowarsch D; Otlewski J; Zakrzewska M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31443196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.